Found 10 matching trials
To Evaluate the Food Effect on Pharmacokinetic Profiles and Safety in Healthy Volunteers
PHASE1This is a randomized, open-label, single dose, crossover, phase 1 trial to ...
Location
Multiple Locations
Clinical Study to Evaluate the Food Effect of CKD-383 0.5/10/1000mg in Healthy Volunteers
PHASE1This study is a randomized, open-label, single dose, crossover study to eva...
Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-383 0.5/10/1000mg in Healthy Volunteers
PHASE1This study is a randomized, open-label, single dose, crossover study to eva...
Location
H Plus Yangji Hospital
Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic of CKD-501, D745, and D150 for Healthy Subjects in Fed State.
PHASE1This is a Randomized, open-label, single oral dosing, two-sequence, and two...
Location
Chung-Ang University Gwangmyeong Hospital
Evaluate the Pharmacokinetics and Safety Between the Administration of CKD-383 and the Co-administration of CKD-501, D744, and D150
PHASE1Evaluate the Pharmacokinetics and Safety Between the Administration of CKD-...
Location
CHA Bundang Medical Center, CHA University
A Clinical Trial to Evaluate the Pharmacokinetic Profiles and Safety of CKD-383.
PHASE1A clinical trial to evaluate the pharmacokinetic profiles and safety of CKD...
Location
Severance Hospital
Clinical Study to Evaluate the Food Effect of CKD-383 0.5/25/1000mg in Healthy Volunteers
PHASE1This study is a randomized, open-label, single dose, crossover study to eva...
Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-383 0.5/25/1000mg in Healthy Volunteers
PHASE1This study is a randomized, open-label, single dose, crossover study to eva...
Location
H Plus Yangji Hospital
Evaluate the Pharmacokinetics and Safety Between the Treatment of CKD-383 and Treatment of CKD-501, D745, D150, and D029
PHASE1Evaluate the Pharmacokinetics and Safety Between the Administration of CKD-...
Location
CHA Bundang Medical Center, CHA University
Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-383 0.25/12.5/1000mg in Healthy Volunteers
PHASE1This study is a randomized, open-label, single dose, crossover study to eva...
Location
H Plus Yangji Hospital